Booking Holdings, Broadcom, Boston Scientific, TJX, and EQT Emerge as Top Stocks to Buy or Monitor in 2025
As investors navigate a complex market environment marked by inflation concerns and policy uncertainties, select stocks stand out for their strong fundamentals, technical setups, and growth prospects. Booking Holdings (BKNG), Broadcom (AVGO), Boston Scientific (BSX), TJX Companies (TJX), and EQT Corporation (EQT) have been identified as leading candidates for investment or watchlists based on recent performance and outlook.
Market Context
After a volatile period influenced by political developments and tariff policies, the U.S. stock market has demonstrated resilience. Major indexes such as the S&P 500 and Nasdaq have rebounded from lows and currently trade above key moving averages, signaling potential for further gains. However, investors should remain vigilant for market corrections amid headline-driven volatility.
Investment Criteria
The selection of these stocks follows a disciplined approach emphasizing:
- Consistent quarterly and annual earnings growth of at least 25%
- Innovative products or services driving revenue expansion
- Strong institutional ownership and support
- Favorable technical chart patterns indicating optimal entry points
- This methodology aims to outperform the S&P 500 benchmark over the long term.
1.Booking Holdings (BKNG)
Booking Holdings has surpassed a critical buy point at approximately $5,250 and is approaching a higher consolidation entry near $5,337. The stock exhibits robust relative strength and trades comfortably above its 50-day, 21-day, and 10-day moving averages. Its IBD Composite Rating stands at 94 out of 99, reflecting strong overall performance.
Fundamentally, BKNG boasts a 97 EPS Rating, with earnings per share growing an average of 23% over the past three quarters and a three-year EPS growth rate of 46%. Analysts forecast EPS growth of 15% in 2025 and 16% in 2026. The company’s Q1 2025 EPS rose 22%, and revenue growth guidance of 10%-12% exceeded analyst expectations. Institutional investors hold 55% of shares, underscoring solid backing.
2.Broadcom (AVGO)
Broadcom is forming the right side of a new base with a buy point near $251.88, offering a potential entry zone up to 5% above this level. The stock has rebounded above its 50-day moving average and its relative strength line is approaching a 12-month high. It holds a near-perfect IBD Composite Rating of 99 and an EPS Rating of 98.
Wall Street anticipates full-year EPS growth of 36% in fiscal 2025, followed by 18% growth in 2026. Institutional ownership accounts for 48% of shares, including positions in prominent funds like Allspring Growth and Fidelity Contrafund. Broadcom’s strategic positioning in AI, electrification, telecom infrastructure, and automation, along with a recent $10 billion share repurchase plan, supports its bullish outlook.
3.Boston Scientific (BSX)
Boston Scientific recently cleared a double-bottom base buy point at $104.35 and surpassed a handle entry at $105.74. The stock reclaimed its 50-day and shorter-term moving averages after finding support at its 200-day line. It holds an IBD Composite Rating of 98 and an EPS Rating of 96.
Earnings have grown by an average of 29% over the last three quarters, with 16% EPS growth expected in 2025 and 13% in 2026. Q1 2025 results beat estimates, with $4.66 billion in sales (up 21%) and adjusted EPS of $0.75 (up nearly 34%). Key product lines, including electrophysiology tools and Watchman devices, showed strong organic growth. Institutional ownership stands at 57%, supported by funds such as MFS Growth and Allspring Growth.
4.TJX Companies (TJX)
TJX stock is trading above a double-bottom base entry point of $127.58 and remains buyable up to 5% above this level. The relative strength line is near 12-month highs, and the stock holds a solid IBD Composite Rating of 88 and an EPS Rating of 88.
Recent earnings grew 10% in the last quarter, with a three-quarter average growth of 11%. EPS is projected to rise 6% in the current fiscal year and accelerate to 11% next year. The stock has gained over 10% in 2025 despite broader market weakness. Institutional interest is strong, with a recent upgrade by Citigroup citing favorable conditions for off-price retailers amid tariff-driven market disruptions.
5.EQT Corporation (EQT)
EQT is breaking out from a double-bottom base with a buy point at $55.34 and an alternate entry near $56.66. The stock’s relative strength line has reached new highs, and it holds an IBD Composite Rating of 91 and an EPS Rating of 97.
Earnings have accelerated in the past two quarters, with EPS expected to surge 112% in 2025 and grow 44% in 2026. Institutional ownership is robust at 62%, including major holdings by Fidelity Contrafund. As the largest natural gas producer in the U.S., EQT benefits from favorable industry dynamics and is featured on the IBD Leaderboard of top growth stocks.
Conclusion
These five stocks combine strong earnings growth, technical strength, and institutional support, making them attractive candidates for investors seeking growth opportunities in 2025. Monitoring market trends and adhering to disciplined entry and exit strategies remain essential in navigating ongoing volatility.
Learn more:
